Skip to main navigation Skip to search Skip to main content

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives

  • Xiaohui Tao
  • , Luyao Wang*
  • , Xin Yang
  • , Hewen Jiang
  • , Ning Zhang
  • , Huarui Zhang
  • , Dijie Li
  • , Xiaofei Li
  • , Yihao Zhang
  • , Shenghang Wang
  • , Chuanxin Zhong
  • , Sifan Yu
  • , Meishen Ren
  • , Meiheng Sun
  • , Nanxi Li
  • , Tienan Chen
  • , Yuan Ma
  • , Fangfei Li
  • , Jin Liu
  • , Yuanyuan Yu
    • Hua Yue, Zhenlin Zhang*, Ge Zhang*
*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives'. Together they form a unique fingerprint.
Sort by:

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science